162 related articles for article (PubMed ID: 9354001)
1. Significance of serum ferritin and lactate dehydrogenase in benign and malignant disease of breast.
Kher A; Moghe G; Deshpande A
Indian J Pathol Microbiol; 1997 Jul; 40(3):321-6. PubMed ID: 9354001
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic significance of serum cholinesterase and lactate dehydrogenase in breast cancer.
Khan N; Tyagi SP; Salahuddin A
Indian J Pathol Microbiol; 1991 Apr; 34(2):126-30. PubMed ID: 1752638
[TBL] [Abstract][Full Text] [Related]
3. [The value of evaluating tumor markers: CA 15-3 and ferritin in blood serum of patients grouped as "high risk" for breast cancer].
Kokocińska D; Widala E; Donocik J; Nolewajka E
Przegl Lek; 1999; 56(10):664-7. PubMed ID: 10695382
[TBL] [Abstract][Full Text] [Related]
4. Serum lactate dehydrogenase isoenzymes in breast tumours.
Khurana P; Tyagi N; Salahuddin A; Tyagi SP
Indian J Pathol Microbiol; 1990 Oct; 33(4):355-9. PubMed ID: 2132504
[TBL] [Abstract][Full Text] [Related]
5. Measurement of prostate-specific antigen in detection of benign or malignant breast disease in women.
Romppanen J; Keskikuru R; Kataja V; Eskelinen M; Kosma VM; Savolainen K; Uusitupa M; Mononen I
Br J Cancer; 1999 Mar; 79(9-10):1583-7. PubMed ID: 10188910
[TBL] [Abstract][Full Text] [Related]
6. Serum and tissue LDH levels in patients with breast/gynaecological cancer and benign diseases.
Koukourakis MI; Kontomanolis E; Giatromanolaki A; Sivridis E; Liberis V
Gynecol Obstet Invest; 2009; 67(3):162-8. PubMed ID: 19088479
[TBL] [Abstract][Full Text] [Related]
7. [Serum ferritin level in patients with breast cancer].
Rusinowska Z; Rozek-Lesiak K; Kokocińska D
Pol Tyg Lek; 1988 May; 43(22):706-8. PubMed ID: 3226979
[No Abstract] [Full Text] [Related]
8. Serum lactate dehydrogenase in head and neck malignancy patients.
Singh SK; Hasan SA; Sharma SC; Chandra K; Ali R
Indian J Physiol Pharmacol; 1993 Jan; 37(1):93-4. PubMed ID: 8449558
[TBL] [Abstract][Full Text] [Related]
9. Carcinoembryonic antigen: an invaluable marker for advanced breast cancer.
Pathak KA; Khanna R; Khanna HD; Khanna S; Gupta S; Khanna NN
J Postgrad Med; 1996; 42(3):68-71. PubMed ID: 9715319
[TBL] [Abstract][Full Text] [Related]
10. Oxidant/antioxidant status in blood of patients with malignant breast tumour and benign breast disease.
Polat MF; Taysi S; Gul M; Cikman O; Yilmaz I; Bakan E; Erdogan F
Cell Biochem Funct; 2002 Dec; 20(4):327-31. PubMed ID: 12415567
[TBL] [Abstract][Full Text] [Related]
11. Serum ferritin as a marker of therapeutic response in stage III and IV breast cancer.
Williams MR; Turkes A; Pearson D; Griffiths K; Blamey RW
Eur J Surg Oncol; 1990 Feb; 16(1):22-7. PubMed ID: 2137790
[TBL] [Abstract][Full Text] [Related]
12. Predictive relevance of soluble CD44v6 serum levels for the responsiveness to second line hormone- or chemotherapy in patients with metastatic breast cancer.
Kopp R; Classen S; Wolf H; Gholam P; Possinger K; Wilmanns W
Anticancer Res; 2001; 21(4B):2995-3000. PubMed ID: 11712800
[TBL] [Abstract][Full Text] [Related]
13. Monocyte tissue factor levels in cancer patients.
Lwaleed BA; Francis JL; Chisholm M
Saudi Med J; 2000 Aug; 21(8):722-9. PubMed ID: 11423883
[TBL] [Abstract][Full Text] [Related]
14. Measurement of ferritin-bearing peripheral mononuclear blood cells in cancer patients by radioimmunoassay.
Bluestein BI; Luderer AA; Hess D; Smith D; Meyer KK; Boyle G; Carter AC
Cancer Res; 1984 Sep; 44(9):4131-6. PubMed ID: 6744324
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of the combined use of plurime tumor markers in human breast cancer.
Neri B; Bartalucci S; Cataliotti L; Distante V; Tommasi M; Ciapini A
Cancer Detect Prev; 1988; 13(2):115-21. PubMed ID: 3072081
[TBL] [Abstract][Full Text] [Related]
16. [Serum lactate dehydrogenase and its isoenzymes in nasopharyngeal carcinoma in Tunisia].
Jmal A; Abdennebi M; Boussen H; Abaza H; Gara S; Bendjemana K; Harzallah L; Guemira F; Ghanem A
Tunis Med; 2005 Apr; 83(4):218-20. PubMed ID: 15966667
[TBL] [Abstract][Full Text] [Related]
17. Significance of circulating hepatocyte growth factor level as a prognostic indicator in primary breast cancer.
Toi M; Taniguchi T; Ueno T; Asano M; Funata N; Sekiguchi K; Iwanari H; Tominaga T
Clin Cancer Res; 1998 Mar; 4(3):659-64. PubMed ID: 9533534
[TBL] [Abstract][Full Text] [Related]
18. Serum c-erbB-2 protein in breast cancer patients.
Chearskul S; Sinlarat P; Bhothisuwan K; Churintrapun M; Ornrhebroi S; Klinsala N; Sungkabunchoo S
J Med Assoc Thai; 2000 Aug; 83(8):886-93. PubMed ID: 10998842
[TBL] [Abstract][Full Text] [Related]
19. Serum lactate dehydrogenase level in various malignancies.
Malhotra P; Sidhu LS; Singh SP
Neoplasma; 1986; 33(5):641-7. PubMed ID: 3785469
[TBL] [Abstract][Full Text] [Related]
20. Elevated level of cell-free plasma DNA is associated with breast cancer.
Zhong XY; Ladewig A; Schmid S; Wight E; Hahn S; Holzgreve W
Arch Gynecol Obstet; 2007 Oct; 276(4):327-31. PubMed ID: 17431649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
